New hope against superbugs: gut cleanse trial launches
NCT ID NCT07525089
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a treatment called BM111 to remove two types of drug-resistant bacteria (CRE and VRE) from the gut of healthy carriers. About 38 adults who carry these bacteria but don't have an active infection will receive BM111 or a placebo. The goal is to see if BM111 can safely reduce or eliminate these bacteria, lowering the risk of future infections.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VRE COLONIZATION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Severance Hospital
Seoul, 03722, South Korea